How do you alter the inside of a closed bag without opening it? It’s not a trick question, as researchers in Braunschweig, Germany, have achieved just that. [ + ]

Compumedics (ASX:CMP) has finally secured the short-term funding needed to help it process a significant order backlog for its diagnostics products. [ + ]

QRxPharma (ASX:QRX) has been granted a US patent covering linking morphine and oxycodone molecules to form a more potent hybrid compound. [ + ]

The Agricultural Biotechnology Council of Australia (ABCA) invites you to join its email list to receive regular updates on current and emerging issues in agricultural biotechnology in Australia. [ + ]

Advanced technologies help researchers visualise cancer spreading and improve drug delivery. [ + ]

University of Queensland (UQ) commercialisation company UniQuest has announced the appointment of its new CEO, Dr Dean Moss. [ + ]

A group of leading scientists have claimed that the outlawing of psychoactive drugs amounts to the worst case of scientific censorship since the Catholic Church banned the works of Copernicus and Galileo. [ + ]

Bionomics (ASX:BNO) has completed enrolment for the first clinical trial involving a vascular disrupting agent - the company’s BNC105 candidate - with an mTOR inhibitor. [ + ]

Australian researchers spend an average of 34 working days preparing a single NHMRC grant application. [ + ]

iSonea (ASX:ISN) has released the results of a survey suggesting that 80% of Australian GPs and 62% of paediatricians would recommend its upcoming mobile wheeze-monitoring system. [ + ]

In order to manage vulnerable kangaroo populations, it is important to identify the distribution of species across particular areas. Researchers at The University of Adelaide have developed a simple DNA test which identifies the animals from something they leave everywhere - their poo. [ + ]

Universal Biosensors (ASX:UBI) has picked up a Victorian government manufacturing award recognising innovative use of technology in its production processes. [ + ]

Patrys (ASX:PAB) has picked up a patent covering anticancer antibody PAT-LM1 in a second market - New Zealand. [ + ]

An infectious diseases researcher has been recognised for his dedication to patients and biomedical research. [ + ]

A new purpose-built technology hub to support emerging high-tech businesses has been established in South Australia. [ + ]